Home / Practice Areas / Business and Civil Practice / Supremes tweaking Twiqbal?

Supremes tweaking Twiqbal?

Securities fraud ruling could impact pleading standards and more

The U.S. Supreme Court's recent ruling that non-scientific reports can be used by investors to support a securities fraud claim against a drug manufacturer could give a boost to plaintiffs in a host of other areas of litigation, including drug liability and mass tort claims.